Cellulose nanofiber dispersion as a new submucosal injection material for endoscopic treatment: preliminary experimental study

Abstract

Background and aims Although various solutions have been tested for submucosal injections during endoscopic treatment, the ideal solution has not been established. We investigated the suitability of a cellulose nanofiber (CNF) dispersion with high viscosity and thixotropy as a potential submucosal injection material for endoscopic treatment.

Methods We evaluated the catheter injectability and mucosa-elevating capacity of CNF dispersion compared with sodium hyaluronate (SH) solution, which has been reported to be a promising submucosal injection solution. The catheter injectability of CNF dispersion was examined under conditions equivalent to those used clinically in endoscopic treatment. The mucosa-elevating capacity of CNF dispersion was examined in porcine stomachs.

Results There was no significant difference between the catheter injectability of 0.4 % CNF dispersion and 0.4 % SH solutions; however, 0.4 % CNF dispersion maintained significantly higher and longer elevation of the submucosal layer than 0.4 % SH solution. A clear separation of the mucosal layer from the underlying muscle layer was achieved by injecting 0.4 % CNF dispersion.

Conclusion This preliminary study suggests that CNF dispersion could be an ideal submucosal injection material for endoscopic treatment because of its unique high thixotropy index.

Publication History

Received: 03 October 2019

Accepted: 06 January 2020

Article published online:
17 April 2020

• References

• 1 Tada M, Murakami A, Karita M. et al. Endoscopic resection of early gastric cancer. Endoscopy 1993; 25: 445-450
• 2 Oka S, Tanaka S, Kaneko I. et al. Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer. Gastrointest Endosc 2006; 64: 877-883
• 3 Fujishiro M, Yahagi N, Kashimura K. et al. Comparison of various submucosal injection solutions for maintaining mucosal elevation during endoscopic mucosal resection. Endoscopy 2004; 36: 579-583
• 4 Tran RT, Palmer M, Tang SJ. et al. Injectable drug-eluting elastomeric polymer: a novel submucosal injection material. Gastrointest Endosc 2012; 75: 1092-1097
• 5 Kusano T, Etoh T, Akagi T. et al. Evaluation of 0.6% sodium alginate as a submucosal injection material in endoscopic submucosal dissection for early gastric cancer. Dig Endosc 2014; 26: 638-645
• 6 Brown EE, Hu D, Abu Lail N. et al. Potential of nanocrystalline cellulose-fibrin nanocomposites for artificial vascular graft applications. Biomacromolecules 2013; 14: 1063-1071
• 7 Nuutila K, Laukkanen A, Lindford A. et al. Inhibition of skin wound contraction by nanofibrillar cellulose hydrogel. Plast Reconstr Surg 2018; 141: 357-366
• 8 Barriga S. 2,2,6,6-Tetramethylpiperidin-1-oxyl (TEMPO). Synlett 2001; 4: 563
• 9 Isogai A, Saito T, Fukuzumi H. TEMPO-oxidized cellulose nanofibers. Nanoscale 2011; 3: 71-85
• 10 Vartiainen J, Pohler T, Sirola K. et al. Health and environmental safety aspects of friction grinding and spray drying of microfibrillated cellulose. Cellulose 2011; 18: 775-786